Tekla Healthcare Investors (Formerly known as H&Q Healthcare Investors) is a diversified closed-end healthcare fund traded on the New York Stock Exchange under the ticker HQH. HQH primarily invests in the healthcare industry (including biotechnology, medical devices, and pharmaceuticals). The Fund's objective is to provide long-term capital appreciation through investments in companies in the healthcare industry believed to have significant potential for above-average long-term growth. Selection will emphasize the smaller, emerging companies with a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. Management believes this provides a unique opportunity not usually available to mutual fund investors.